Stay updated on Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays a new revision label v3.6.6, replacing v3.6.5. This indicates a page update with no apparent changes to the study data or sections.
    Difference
    0.1%
    Check dated 2026-08-29T20:03:57.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The revision label at the bottom of the page updated from v3.6.4 to v3.6.5, indicating a minor release of the page's software or content. This update does not change the study details or visible information on the page.
    Difference
    0.0%
    Check dated 2026-08-08T23:31:51.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor maintenance release.
    Difference
    0.0%
    Check dated 2026-07-25T13:06:17.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.2 to v3.6.3, indicating an internal update to the page's underlying platform. There is no visible impact on the study information or user interactions.
    Difference
    0.0%
    Check dated 2026-07-04T04:00:06.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.0 to v3.6.2, indicating a new iteration of the document. This is a minor update that typically reflects small content or formatting adjustments rather than major changes to the page's core information.
    Difference
    0.0%
    Check dated 2026-06-27T01:53:38.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    Adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates recruitment status to 'No longer looking for participants'. Also updates the Interventions label formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and adds revision: v3.6.0, replacing the previous v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T23:52:04.000Z thumbnail image

Stay in the know with updates to Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page.